Clinical and Laboratory Parameters of Myelodysplastic Syndromes at Upper Egypt
NCT06244173 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2024-02-06
Summary
The aim of our study is to assess clinical \& laboratory parameters of adult Egyptian myelodysplastic syndrome patients in upper Egypt, its correlation with disease-free survival, overall survival (OS) and acute leukemia transformation.
Conditions
Sponsors & Collaborators
-
Sohag University
lead OTHER
Principal Investigators
-
Asmaa abdelbaset, MD · faculty of medicine - Sohag university
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-06-01
- Primary Completion
- 2023-11-01
- Completion
- 2023-12-01
Countries
- Egypt
Study Locations
More Related Trials
-
Study of the Safety and Efficacy of CC-5013 Treatment For Patients With Myelodysplastic Syndrome
NCT00044382 ·Status: COMPLETED ·Phase: PHASE2
-
Value of Using Pioglitazone in Chronic Myeloid Leukemia Treatment
NCT04883125 ·Status: COMPLETED ·Phase: PHASE2
-
DEC-205/NY-ESO-1 Fusion Protein CDX-1401and Decitabine in Treating Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia
NCT01834248 ·Status: COMPLETED ·Phase: PHASE1
-
An Efficacy Study for Epoetin Alfa in Anemic Patients With Myelodysplastic Syndromes
NCT01381809 ·Status: COMPLETED ·Phase: PHASE3
-
Phase 2 Trial of BN104 as Post-HSCT Maintenance in Acute Leukemia
NCT07101497 ·Status: RECRUITING ·Phase: PHASE2
-
Phase II Hedgehog Inhibitor for Myelodysplastic Syndrome (MDS)
NCT01842646 ·Status: COMPLETED ·Phase: PHASE2
-
Immunophenotyping of Acute b Cell Lymphoblstic Leukemia
NCT04084327 ·Status: UNKNOWN
-
Role of Cbc Indices in Acute Lymphoblastic Leukemia Patients
NCT06746571 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Lenalidomide and Decitabine in High Grade Myelodysplastic Syndromes
NCT00828802 ·Status: COMPLETED ·Phase: PHASE1
-
Amifostine in Treating Patients With Advanced Myelodysplastic Syndrome
NCT00003123 ·Status: UNKNOWN ·Phase: PHASE2
-
Clinical Study of Venetoclax Combined With Azacytiside in the Treatment of Myelodysplastic/Myeloproliferative Neoplasms in Adults
NCT05282719 ·Status: UNKNOWN ·Phase: PHASE2
-
Observational Study for the Evaluation of Incidence of Systemic Mastocytosis in t(8;21) Acute Myeloid Leukemia
NCT05504408 ·Status: RECRUITING
-
Phase I/II Trial to Investigate BI 836858 in Myelodysplastic Syndromes
NCT02240706 ·Status: TERMINATED ·Phase: PHASE2
-
Chronic Myelogenous Leukemia or Philadelphia Chromosome Positive Acute Lymphoblastic Leukemic Study
NCT00978731 ·Status: COMPLETED ·Phase: PHASE1
-
A Clinical Trial Evaluating the Efficacy of Ultra Low Dose of Decitabine in Myelodysplastic Syndromes (MDS)
NCT02779569 ·Status: UNKNOWN ·Phase: NA
-
A Study to Compare the Efficacy and Safety of Oral Azacitidine Plus Best Supportive Care (BSC) Versus Placebo Plus BSC in Participants With International Prognostic Scoring System Revised (IPSS-R) Low- or Intermediate-risk Myelodysplastic Syndrome (MDS)
NCT05469737 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2/PHASE3
-
Maintenance Venetoclax in AML Fit Patients
NCT07244367 ·Status: RECRUITING ·Phase: NA
-
Study of Decitabine Combined With HAAG Regimen in Newly Diagnosed ETP-ALL/LBL, T/M-MPAL and ALL/LBL With Myeloid or Stem Cell Markers Patients
NCT04446130 ·Status: UNKNOWN ·Phase: PHASE3
-
A Study of BN104 in the Treatment of Acute Leukemia
NCT06052813 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
Study of Farnesyl Protein Transferase Inhibitor (FPTI) in Patients With Leukemia (Study P00701)
NCT00034684 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Safety and Efficacy Study of PD-616 Plus Cytarabine to Treat Acute Myelogenous Leukemia or Myelodysplastic Syndrome
NCT01795924 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
AML/MDS Drug Sensitization by in Vivo Chemotherapy Administration
NCT04263181 ·Status: ACTIVE_NOT_RECRUITING
-
Bortezomib, Sorafenib Tosylate, and Decitabine in Treating Patients With Acute Myeloid Leukemia
NCT01861314 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Induction Therapy With Cytarabine, High-Dose Mitoxantrone and Dasatinib for Patients With Philadelphia-Chromosome Positive (Ph+) Acute Lymphoblastic Leukemia
NCT00940524 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of Decitabine Given to Adults With Advanced-Stage Myelodysplastic Syndromes
NCT00260065 ·Status: COMPLETED ·Phase: PHASE2